Baofeng Yang

21.7k total citations · 2 hit papers
445 papers, 15.4k citations indexed

About

Baofeng Yang is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Cancer Research. According to data from OpenAlex, Baofeng Yang has authored 445 papers receiving a total of 15.4k indexed citations (citations by other indexed papers that have themselves been cited), including 276 papers in Molecular Biology, 140 papers in Cardiology and Cardiovascular Medicine and 88 papers in Cancer Research. Recurrent topics in Baofeng Yang's work include Cardiac electrophysiology and arrhythmias (74 papers), Ion channel regulation and function (72 papers) and MicroRNA in disease regulation (50 papers). Baofeng Yang is often cited by papers focused on Cardiac electrophysiology and arrhythmias (74 papers), Ion channel regulation and function (72 papers) and MicroRNA in disease regulation (50 papers). Baofeng Yang collaborates with scholars based in China, Canada and Australia. Baofeng Yang's co-authors include Yanjie Lu, Zhiguo Wang, Chaoqian Xu, Zhenwei Pan, Yong Zhang, Xiaobin Luo, Yunlong Bai, Hongli Shan, De‐Li Dong and Baoxin Li and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Baofeng Yang

425 papers receiving 15.2k citations

Hit Papers

The muscle-specific microRNA miR-1 regulates cardiac arrh... 2007 2026 2013 2019 2007 2018 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Baofeng Yang China 62 9.8k 4.7k 3.9k 1.2k 991 445 15.4k
Chen Chen China 61 7.8k 0.8× 4.0k 0.8× 1.9k 0.5× 896 0.8× 1.2k 1.2× 501 14.9k
Markus Meyer United States 49 7.3k 0.7× 2.7k 0.6× 4.3k 1.1× 778 0.7× 672 0.7× 206 12.8k
Dao Wen Wang China 73 9.5k 1.0× 3.0k 0.6× 6.2k 1.6× 1.7k 1.4× 1.3k 1.3× 605 21.3k
Yunzeng Zou China 61 7.1k 0.7× 1.5k 0.3× 5.2k 1.3× 1.8k 1.5× 1.3k 1.3× 307 13.0k
Yan Chen China 65 8.4k 0.9× 1.5k 0.3× 2.3k 0.6× 1.0k 0.9× 1.9k 1.9× 416 13.9k
Rama Natarajan United States 79 10.0k 1.0× 4.2k 0.9× 1.6k 0.4× 2.3k 1.9× 2.4k 2.5× 246 18.5k
Thomas Thum Germany 86 15.2k 1.5× 11.7k 2.5× 5.6k 1.4× 2.6k 2.2× 1.5k 1.5× 410 24.5k
Yang Yang China 73 9.7k 1.0× 2.9k 0.6× 1.7k 0.4× 1.8k 1.6× 2.6k 2.7× 595 19.4k
Hidenori Koyama Japan 68 5.9k 0.6× 1.8k 0.4× 2.3k 0.6× 1.7k 1.5× 1.5k 1.5× 414 15.1k
Yun Zhang China 60 5.5k 0.6× 1.4k 0.3× 3.7k 1.0× 2.2k 1.9× 2.4k 2.4× 572 14.5k

Countries citing papers authored by Baofeng Yang

Since Specialization
Citations

This map shows the geographic impact of Baofeng Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Baofeng Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Baofeng Yang more than expected).

Fields of papers citing papers by Baofeng Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Baofeng Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Baofeng Yang. The network helps show where Baofeng Yang may publish in the future.

Co-authorship network of co-authors of Baofeng Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Baofeng Yang. A scholar is included among the top collaborators of Baofeng Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Baofeng Yang. Baofeng Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Hongxia, Lingling Qi, Xuefei Feng, et al.. (2025). Obesity-driven oleoylcarnitine accumulation in tumor microenvironment promotes breast cancer metastasis-like phenotype. Acta Pharmaceutica Sinica B. 15(4). 1974–1990.
2.
Zhao, Xin, Chao Chen, Xuefei Feng, et al.. (2025). Emd-D inhibited ovarian cancer progression via PFKFB4-dependent glycolysis and apoptosis. Chinese Journal of Natural Medicines. 23(4). 431–442.
3.
Hu, Nan, Cheng Zeng, Yi Cao, et al.. (2025). Therapeutic potential of Shilong Qingxue Granule and its extract against glutamate induced neural injury: Insights from in vivo and in vitro models. Journal of Ethnopharmacology. 342. 119396–119396.
5.
Hu, Nan, et al.. (2023). Baicalein improves Na2SeO3 induced cataract by enhancing the antioxidant capacity of juvenile Sprague Dawley Rat. Journal of Ethnopharmacology. 320. 117433–117433. 2 indexed citations
7.
Liu, Xin, Xingda Li, Yang Zhang, et al.. (2023). Cullin-associated and neddylation-dissociated protein 1 (CAND1) alleviates NAFLD by reducing ubiquitinated degradation of ACAA2. Nature Communications. 14(1). 4620–4620. 16 indexed citations
9.
Liu, Xue, Weina Han, Na An, et al.. (2021). Kanglexin protects against cardiac fibrosis and dysfunction in mice by TGF-β1/ERK1/2 noncanonical pathway. Frontiers in Pharmacology. 11. 572637–572637. 3 indexed citations
11.
Wei, Zhenhong, Wengang Zhang, Li J, et al.. (2020). Anti-Inflammatory Effects of Magnetically Targeted Mesenchymal Stem Cells on Laser-Induced Skin Injuries in Rats. SHILAP Revista de lepidopterología. 1 indexed citations
12.
Wang, Xinhui, Shuang Yang, Na Sun, et al.. (2020). Kanglexin accelerates diabetic wound healing by promoting angiogenesis via FGFR1/ERK signaling. Biomedicine & Pharmacotherapy. 132. 110933–110933. 34 indexed citations
13.
Zhang, Mingyu, Yuan Jiang, Xiaofei Guo, et al.. (2019). Long non‐coding RNA cardiac hypertrophy‐associated regulator governs cardiac hypertrophy via regulating miR‐20b and the downstream PTEN/AKT pathway. Journal of Cellular and Molecular Medicine. 23(11). 7685–7698. 45 indexed citations
14.
Tong, Shuang, Hui Zhang, Xia Li, et al.. (2018). Prevalence of hypertension in cold and non-cold area of China: a Meta-analysis. Chin J Endemiol. 37(5). 420–425. 2 indexed citations
15.
Pan, Zhenwei, Xuelin Sun, Hongli Shan, et al.. (2012). MicroRNA-101 Inhibited Postinfarct Cardiac Fibrosis and Improved Left Ventricular Compliance via the FBJ Osteosarcoma Oncogene/Transforming Growth Factor-β1 Pathway. Circulation. 126(7). 840–850. 262 indexed citations
16.
Yang, Baofeng, et al.. (2011). Bone marrow-derived stem cells promote glomerular repair and regeneration in progressive glomerulosclerosis rat model. 27(11). 850–853. 1 indexed citations
17.
Li, Xuelian, et al.. (2010). The ionic mechanisms of long QT interval in diabetic rabbits. Journal of Geriatric Cardiology. 7(1). 25–29. 2 indexed citations
18.
Qi, Zhiping, Shanshan Shi, Yunlong Bai, et al.. (2008). [Effect of sophocarpine on HERG K+ channels].. PubMed. 43(1). 44–9. 4 indexed citations
19.
Li, Weimin, Yue Li, Jiyi Zhao, et al.. (2007). Safety and feasibility of emergent percutaneous coronary intervention with the transradial access in patients with acute myocardial infarction. Chinese Medical Journal. 120(7). 598–600. 36 indexed citations
20.
Zhou, Jin, Ran Meng, Limin Li, Jianping Jia, & Baofeng Yang. (2006). Protective Effect of Ganglioside on Human Cortical Neuron Treated by Arsenic Trioxide. Zhōnghuá yàoxué zázhì. 41(1). 29–33. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026